High Incidence of Haemophilus influenzae Type b Infection in Children in Pacific Island Countries

Clinical Infectious Diseases

Volumn 37, Issue 12, 2003, Pages 1593-1599

  Russell, F M ^a   Carapetis, J R ^a,b   Mansoor, O ^c   Darcy, A ^d   Fakakovi, T ^e   Metai, A ^f   Potoi, N T ^g   Wilson, N ^h   Mulholland, E K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d National Referral Hospital   (Solomon Islands)

^e Paediatric Services   (Tonga)

^f Ministry of Health   (Kiribati)

^g Preventive Health Services   (Samoa)

^h Public Health Physician ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG COST; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INCIDENCE; MENINGITIS; PACIFIC ISLANDS; PNEUMONIA; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

CHILD; COST OF ILLNESS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INCIDENCE; MENINGITIS, HAEMOPHILUS; PACIFIC ISLANDS; POLYSACCHARIDES, BACTERIAL;

EID: 0347288600     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379717     Document Type: Article

References (22)

1. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17.
2. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340:592-4.
3. Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group. Arch Pediatr Adolesc Med 1994; 148:51-6.
4. McIntyre PB, Chey T, Smith WT. The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region. Med J Aust 1995; 162:245-8.
5. Wilson N, Mansoor O, Wenger J, et al. Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji. Vaccine 2003; 21:1907-12.
6. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998; 17(9 Suppl):S117-22.
7. WHO position paper. Haemophilus influenzae type b (Hib) vaccines. Weekly Epidemiological Record 1998; 73:64-8.
8. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349:1191-7.
9. Levine OS, Lagos R, Munoz A, et al. Denning the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type-b. Pediatr Infect Dis J 1999; 18:1060-4.
10. Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol Rev 1999; 21:43-55.
11. World Health Organization (WHO). Estimating the local burden of Haemophilus influenzae type b (Hib) disease preventable by vaccination: a rapid assessment tool, 2001. WHO document no. WHO/V&B/ 01.27. Geneva: WHO, 2001.
12. Anglaret X, Buissonniere RF, Duval P, Morlat C, Menager C. Invasive Haemophilus influenzae disease of Melanesian and Caucasian children in New Caledonia. Pediatr Infect Dis J 1993; 12:888-9.
13. Carroll K, Carroll C. The epidemiology of bacterial meningitis occurring in a Pacific Island population. P N G Med J 1993; 36:234-42.
14. World Health Organization (WHO). Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. WHO document no. WHO/ V&B/02.18. Geneva: WHO, 2002.
15. Voss LM, Lennon D, Gilles M. Haemophilus influenzae type b disease in Auckland children 1981-87. N Z Med J 1989; 102:149-51.
16. Lennon D, Voss L, Gilles M, Heffernan H. Epidemiology of invasive Haemophilus influenzae type b disease in New Zealand (1978-1987). Pediatr Res 1989; 25:183A.
17. Wilson N, Wenger J, Mansoor O, Baker M, Martin D. The beneficial impact of Hib vaccine on disease rates in New Zealand children. N Z Med J 2002; 115:U122.
18. Adegbola RA, Mulholland EK, Falade AG, et al. Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 1996; 16:103-11.
19. Peltola H. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. Bull World Health Organ 1999; 77:878-87.
20. Lau YL. Haemophilus influenzae type b diseases in Asia. Bull World Health Organ 1999; 77:867-8.
21. World Health Organization (WHO). Laboratory methods for the diagnosis of meningitis. WHO document no. WHO/CDS/CSR/EDC/ 99.7. Geneva: WHO, 1999.
22. Shann F, Gratten M, Germer S, Linnemann E, Hazlett D, Payne R. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet 1984; 2:537-41.